Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Midnight Trader

Today's small-cap stocks to watch Add to ...

Paladin Labs Inc. , which closed slightly higher on Friday, announced today that it has entered into a license and supply agreement with Nuvo Research Inc. granting Paladin exclusive Canadian rights to market and sell Synera. Under the terms of the agreements, Nuvo will receive a double digit royalty on net sales of Synera in Canada and will supply Synera to Paladin.

TrueContext Mobile Solutions Corp. today announced the first-quarter results for its three months ended March 31, 2012. Total revenue for the three months of $558,437 represented an increase of 93 per cent over total revenue for the first quarter of 2011 of $288,788. First-quarter net loss for 2012 was $585,975 compared to first quarter 2011 net loss of $582,158 and fourth quarter 2011 net loss of $748,856.

Miranda Gold Corp. , which closed 8 per cent higher on Friday, announced today that it has started its 2012 drilling program on its Ester Dome project located in the Fairbanks mining district of Alaska.

Belo Sun Mining Corp. announced today that it has acquired the material surface rights at its 100 per cent owned Volta Grande gold project in Para State, Brazil. The company acquired surface rights for an area covering 1,734 hectares.

Lake Shore Gold Corp. announced last night that the company had commenced safety, ventilation and maintenance checks at its Timmins West Mine as of 7.00 pm on Sunday, May 27, 2012, with full production at the mine to resume this morning at 7.00 am.

Petaquilla Minerals Ltd. reported that it has filed a revised technical report relating to its Lomero-Poyatos project. It had been submitted to the British Columbia Securities Commission and addresses the deficiencies noted in the company's May 3, 2012, press release.

Afferro Mining Inc. announced details of its NI 43-101 compliant Preliminary Economic Assessment for the Nkout Iron Ore Project in Cameroon. It said the PEA indicates that the project is economically viable.

Cipher Pharmaceuticals Inc. , which fell more than 7 per cent from year highs on Friday, announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne. Absorica is expected to be launched in the U.S. in fourth quarter 2012.

Hawk Exploration Ltd. reported net income of $0.5-million in the first quarter of 2012 compared to a net loss of $0.1-million in first quarter 2011.

The Cash Store Australia Holdings Inc. , which is trading close to a year low 13 cents, reported a third-quarter net loss of $3.1-million, compared to a net loss of $915,000 in the third quarter of last year.

Report Typo/Error

Follow us on Twitter: @GlobeInvestor



Next story




Most popular videos »

More from The Globe and Mail

Most popular